Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China

Infection, Genetics and Evolution

Volumn 27, Issue , 2014, Pages 271-276

  Zhang, Chuanming ^a   Xu, Xiuyu ^a   Pu, Shuli ^a   Huang, Shifeng ^a   Sun, Jide ^a   Yang, Shuangshuang ^a   Zhang, Liping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Aminoglycosides; Carbapenem non susceptible; Carbapenemases; Escherichia coli; Extended spectrum lactamases; Fluoroquinolones

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; QUINOLONE DERIVATIVE; QUINOLONE;

AAC(60) IB CR GENE; AAC(60) IB GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARMA GENE; ARTICLE; BACTERIUM ISOLATE; BLACTX M 14 GENE; BLACTX M 3 GENE; BLACTX M 55 GENE; BLAKPC 2 GENE; BLATEM GENE; CARBAPENEM NON SUSCEPTIBLE ESCHERICHIA COLI; CARBAPENEMASE GENE; CONTROLLED STUDY; ESBL GENE; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QNRA GENE; QNRB GENE; QNRC GENE; QNRD GENE; QNRS GENE; RMTB GENE; CHINA; CROSS INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; GENOTYPE; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; TEACHING HOSPITAL; BACTERIAL GENE; BACTERIUM DETECTION; BLACTX M GENE; BLAIMP GENE; BLAKPC GENE; BLANDM GENE; BLASHV GENE; BLASME GENE; BLAVIM GENE; GENE IDENTIFICATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; GENOTYPE; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE; QUINOLONES;

EID: 84907361772     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.07.031     Document Type: Article

References (34)

1. Biendo M., Manoliu C., Laurans G., Castelain S., Canarelli B., Thomas D., Hamdad F., Rousseau F., Eb F. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae. Res. Microbiol. 2008, 159:590-594.
2. Branger C., Zamfir O., Geoffroy S., Laurans G., Arlet G., Thien H.V., Gouriou S., Picard B., Denamur E. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg. Infect. Dis. 2005, 11:54-61.
3. Cai J.C., Zhou H.W., Zhang R., Chen G.X. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob. Agents Chemother. 2008, 52:2014-2018.
4. Cai J.C., Zhang R., Hu Y.Y., Zhou H.W., Chen G.X. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob. Agents Chemother. 2014, 58:1146-1152.
5. Chen L., Hu H., Chavda K.D., Zhao S., Liu R., Liang H., Zhang W., Wang X., Jacobs M.R., Bonomo R.A., Kreiswirth B.N. Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China. Antimicrob. Agents Chemother. 2014, 58:2422-2425.
6. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically 2009, CLSI, Wayne, PA, USA, approved standard M07-A8. eighth ed.
7. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22 2012, CLSI, Wayne, PA, USA.
8. Doumith M., Ellington M.J., Livermore D.M., Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 2009, 63:659-667.
9. Folster J.P., Rickert R., Barzilay E.J., Whichard J.M. Identification of the aminoglycoside resistance determinants armA and rmtC among non-typhi Salmonella isolates from humans in the United States. Antimicrob. Agents Chemother. 2009, 53:4563-4564.
10. Hu F.P., Zhu D.M., Wang F., Jiang X.F., Yang Q., Xu Y.C., Zhang X.J., Sun Z.Y., Chen Z.J., Wang C.Q., Wang A.M., Ni Y.X., Sun J.Y., Yu Y.S., Lin J., Shan B., Du Y., Xu Y.H., Shen J.L., Zhang H., Kong J., Zhuo C., Su D.H., Zhang Z.X., Ji P., Hu Y.J., Ai X.M., Huang W.X., Jia B., Wei L.H., Wu L. 2011 CHINET surveillance of bacterial resistance in China. Chin. J. Infect. Chemother. 2012, 12:321-329. (In Chinese).
11. Huang S., Dai W., Sun S., Zhang X., Zhang L. Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae. PLoS One 2012, 7:e47636.
12. Ko K.S., Lee M.Y., Song J.H., Lee H., Jung D.S., Jung S.I., Kim S.W., Chang H.H., Yeom J.S., Kim Y.S., Ki H.K., Chung D.R., Kwon K.T., Peck K.R., Lee N.Y. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis. 2008, 61:453-459.
13. Livermore D.M., Mushtaq S., Warner M., Zhang J.C., Maharjan S., Doumith M., Woodford N. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J. Antimicrob. Chemother. 2011, 66:48-53.
14. Ma L., Lin C.J., Chen J.H., Fung C.P., Chang F.Y., Lai Y.K., Lin J.C., Siu L.K. Taiwan surveillance of antimicrobial resistance project. Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-Type extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 2009, 53:104-111.
15. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 2005, 49:71-76.
16. Martinez-Martinez L., Eliecer Cano M., Manuel Rodriguez-Martinez J., Calvo J., Pascual A. Plasmid-mediated quinolone resistance. Expert Rev. Anti Infect. Ther. 2008, 6:685-711.
17. Miriagou V., Cornaglia G., Edelstein M., Galani I., Giske C.G., Gniadkowski M., Malamou-Lada E., Martinez-Martinez L., Navarro F., Nordmann P., Peixe L., Pournaras S., Rossolini G.M., Tsakris A., Vatopoulos A., Cantón R. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 2010, 16:112-122.
18. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 2011, 17:1791-1798.
19. O'Neill A.J. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria. Expert Opin. Investig. Drugs 2008, 17:297-302.
20. Paterson D.L. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin. Microbiol. Infect. 2000, 6:460-463.
21. Pfeifer Y., Cullik A., Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int. J. Med. Microbiol. 2010, 300:371-379.
22. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., Bush K., Hooper D.C. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 2006, 12:83-88.
23. Shin J.H., Jung H.J., Lee J.Y., Kim H.R., Lee J.N., Chang C.L. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. Microb. Drug Resist. 2008, 14:221-226.
24. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance. A multifaceted threat. Clin. Microbiol. Rev. 2009, 22:664-689.
25. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 1995, 33:2233-2239.
26. Xiao Y.H., Giske C.G., Wei Z.Q., Shen P., Heddini A., Li L.J. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist. Updates 2011, 14:236-250.
27. Yang F.C., Yan J.J., Hung K.H., Wu J.J. Characterization of Ertapenem-resistant Enterobacter cloacae in a Taiwanese University Hospital. J. Clin. Microbiol. 2012, 50:223-226.
28. Yang H., Chen H., Yang Q., Chen M., Wang H. High prevalence of plasmid-mediated quinolone resistance genes qnr and AAC(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Antimicrob. Agents Chemother. 2008, 52:4268-4273.
29. Yang J., Luo Y., Cui S., Wang W., Han L. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants. Microb. Drug Resist. 2011, 17:363-367.
30. Yang J., Luo Y., Li J., Ma Y., Hu C., Jin S., Ye L., Cui S. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants. J. Antimicrob. Chemother. 2010, 65:453-459.
31. Zacharczuk K., Piekarska K., Szych J., Zawidzka E., Sulikowska A., Wardak S., Jagielski M., Gierczynski R. Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland. Antimicrob. Agents Chemother. 2011, 55:443-446.
32. Zhang Y., Yang J., Ye L., Luo Y., Wang W., Zhou W., Cui Z., Han L. Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China. Microb. Drug Resist. 2012, 18:465-470.
33. Zhou T., Zhang X., Guo M., Ye J., Lu Y., Bao Q., Chi W. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, Southern China. Jpn. J. Infect. Dis. 2013, 66:96-102.
34. Zurfluh K., Abgottspon H., Hächler H., Nüesch-Inderbinen M., Stephan R. Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One 2014, 9:e95864.